Volume 19, Issue 1, Pages (April 2017)

Slides:



Advertisements
Similar presentations
Irreplaceability of Neuronal Ensembles after Memory Allocation Naoki Matsuo Cell Reports Volume 11, Issue 3, Pages (April 2015) DOI: /j.celrep
Advertisements

Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression  Weixin Wang, Meghan Corrigan-Cummins,
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile.
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Volume 150, Issue 4, Pages (April 2016)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study  Marco Lo Iacono, PhD, Valentina.
Volume 5, Issue 1, Pages (October 2013)
The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Jianbin Wang, H. Christina Fan, Barry Behr, Stephen R. Quake  Cell 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Volume 145, Issue 5, Pages e1 (November 2013)
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma by Aldo M. Roccaro, Antonio.
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Volume 74, Issue 5, Pages (November 2018)
Mohammed El-Kebir, Gryte Satas, Layla Oesper, Benjamin J. Raphael 
Volume 46, Issue 2, Pages (February 2017)
Volume 25, Issue 1, Pages (January 2014)
Mark A. Rubin, Gabriele Girelli, Francesca Demichelis  European Urology 
Volume 72, Issue 4, Pages (October 2017)
Volume 27, Issue 3, Pages (March 2015)
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression  Weixin Wang, Meghan Corrigan-Cummins,
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Volume 9, Issue 4, Pages (April 2006)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Identification of a MEK2 mutation in a melanoma sample resistant to dabrafenib/trametinib. Identification of a MEK2 mutation in a melanoma sample resistant.
Volume 29, Issue 5, Pages (May 2016)
Amel A. Albibas, Matthew J. J. Rose-Zerilli, Chester Lai, Reuben J
Volume 13, Issue 2, Pages (October 2015)
SNPitty The Journal of Molecular Diagnostics
Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma  Rachel D. Melamed, Iraz T. Aydin, Geena Susan Rajan, Robert.
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Volume 150, Issue 4, Pages (April 2016)
Volume 7, Issue 1, Pages (April 2014)
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Volume 19, Issue 10, Pages (June 2017)
Volume 24, Issue 4, Pages (July 2018)
Volume 4, Issue 6, Pages (September 2013)
Volume 150, Issue 6, Pages (September 2012)
High Frequency of Loss of Heterozygosity on Chromosome Region 9p21–p22 but Lack of p16INK4a/p19ARF Mutations in Greek Patients with Basal Cell Carcinoma.
Ashley M. Laughney, Sergi Elizalde, Giulio Genovese, Samuel F. Bakhoum 
Volume 18, Issue 1, Pages (January 2017)
Volume 24, Issue 12, Pages e5 (September 2018)
Volume 24, Issue 8, Pages (August 2018)
Volume 24, Issue 7, Pages (August 2018)
Genetic and Functional Diversity of Propagating Cells in Glioblastoma
Volume 31, Issue 2, Pages (February 2017)
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia by Aldo M. Roccaro, Antonio Sacco, Jiantao.
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 19, Issue 1, Pages (April 2017)
Volume 12, Issue 4, Pages (July 2015)
Spatiotemporal Evolution of the Primary Glioblastoma Genome
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies  Francesca L. Nice,
Volume 29, Issue 5, Pages (May 2016)
Figure 1. T-cell lymphoma–free survival of untreated and IR-exposed Mlh1−/− mice. Kaplan–Meier survival ... Figure 1. T-cell lymphoma–free survival of.
Brennan Decker, Danielle M. Karyadi, Brian W
High-Definition Reconstruction of Clonal Composition in Cancer
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma by Ilyas Sahin, Yawara Kawano, Romanos.
Landscape of genomic alterations in 444 tumors from 429 patients with mCRPC. Landscape of genomic alterations in 444 tumors from 429 patients with mCRPC.
Volume 9, Pages (November 2018)
Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers  Ryoichi Onozato, MD,
Volume 16, Issue 4, Pages (April 2015)
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification 
Delineating cancer evolution with single-cell sequencing
Mutational Analysis of Ionizing Radiation Induced Neoplasms
Volume 25, Issue 4, Pages e3 (October 2018)
Driver pathways and key genes in OSCC
Volume 25, Issue 1, Pages (January 2014)
Presentation transcript:

Volume 19, Issue 1, Pages 218-224 (April 2017) The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma  Yuji Mishima, Bruno Paiva, Jiantao Shi, Jihye Park, Salomon Manier, Satoshi Takagi, Mira Massoud, Adriana Perilla-Glen, Yosra Aljawai, Daisy Huynh, Aldo M. Roccaro, Antonio Sacco, Marzia Capelletti, Alexandre Detappe, Diego Alignani, Kenneth C. Anderson, Nikhil C. Munshi, Felipe Prosper, Jens G. Lohr, Gavin Ha, Samuel S. Freeman, Eliezer M. Van Allen, Viktor A. Adalsteinsson, Franziska Michor, Jesus F. San Miguel, Irene M. Ghobrial  Cell Reports  Volume 19, Issue 1, Pages 218-224 (April 2017) DOI: 10.1016/j.celrep.2017.03.025 Copyright © 2017 The Authors Terms and Conditions

Cell Reports 2017 19, 218-224DOI: (10.1016/j.celrep.2017.03.025) Copyright © 2017 The Authors Terms and Conditions

Figure 1 Concordance of SSNVs Found in Matched BM Clonal PCs and CTCs (A) Rate of synonymous and nonsynonymous mutations are expressed in number of mutations per megabase. Heatmap representation of individual mutations is present in a series of eight paired BM and CTC samples. Breakdown of individual base-substitution rates is shown for each sample as well. (B) Heatmap representation of individual mutations is present in 13 WES CTC samples and 16 targeted sequencing CTC samples. Percentages represent the fraction of tumors harboring at least one mutation in specified genes. Cell Reports 2017 19, 218-224DOI: (10.1016/j.celrep.2017.03.025) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Clustering Analysis of Clonal and Subclonal SSNVs between Matched BM Clonal PCs and CTCs Clustering analysis of CCF for SSNVs between matched BM clonal PCs and CTCs is shown in this figure. Shared clonal SSNVs were defined as events having ≥0.9 CCF in both samples (red). Shared subclonal SSNVs were identified as events having ≥0.05 CCF in both samples (blue). Not shared subclonal SSNVs were defined as events having <0.05 CCF in either BM or CTC samples (green). The size of each cluster indicates the frequency of SSNVs within the same sample. Cell Reports 2017 19, 218-224DOI: (10.1016/j.celrep.2017.03.025) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Concordance of Somatic Copy-Number Alterations Found in Matched BM Clonal PCs and CTCs Arm level of somatic copy-number alterations are compared within the same patient (left, BM; right, CTC). Red indicates amplification, and blue indicates deletion. Cell Reports 2017 19, 218-224DOI: (10.1016/j.celrep.2017.03.025) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Representative Example of Somatic Copy-Number Alterations Found in Matched BM Clonal PCs and CTCs Allelic copy number ratios are shown for both BM (top) and CTC (bottom) samples within the same patient (434 and 453, respectively). Cell Reports 2017 19, 218-224DOI: (10.1016/j.celrep.2017.03.025) Copyright © 2017 The Authors Terms and Conditions